Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT07112118
Starting soon Observational

Multimodal Identification of Depressive Symptoms in the Elderly

NCT07112118 · tracked via the Priya Life Science China tracker
Sponsor
Wuhan Mental Health Centre
Phase
Observational
Started
2025-09-01
Last updated
2025-08-11

Condition(s) studied

Depression

Investigational drug(s) / intervention(s)

data collection

data collection: Collect the facial expressions, audio, text and postural behavior data of the respondents using electronic devices.

Study summary

Screening with depression scales alone is subjective, and relying on single-modal data often leads to incomplete identification of symptoms that are easily missed or misdiagnosed. In this study, we first aim to use artificial intelligence to construct a depression symptom recognition model, concatenate multimodal features such as facial expression, audio, text, and postural behavior, and deeply fuse them to construct a multimodal model.

Eligibility

Sex
ALL
Min age
60 Years
Max age
100 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Elderly individuals aged 60 years or older. * Residents of the community (with residence time of more than 6 months). * Possessing certain reading, writing and comprehension skills, being able to communicate with researchers without obstacles, and being able to independently complete the measurement of various indicators or, although unable to independently fill out the questionnaire, being able to independently make evaluations of the questionnaire items. * Those who have given informed consent. Exclusion Criteria: * Those who meet the diagnostic criteria for cognitive impairment (dementia) as stipulated in DSM-5, and/or who suffer from severe physical diseases (such as advanced cancer, cardiovascular and cerebrovascular diseases, etc.). * Those who are undergoing antidepressant treatment. * Elderly individuals who have had suicidal thoughts in any psychological assessment, should be referred to the psychological hotline platform in Wuhan.

Primary outcome measure(s)

  • Use the PHQ-9 (Patient Health Questionnaire - 9 ) to assess whether the respondents have depressive symptoms. The scale score is one point for each item. — 2025.09.01-2026.09.01
    If the PHQ-9 score is 5 or higher, it is determined as a positive sign of depressive symptoms.

Trial sites (1)

FacilityCityRegionStatus
Wuhan Mental Health Center Wuhan Hubei

More Wuhan Mental Health Centre trials in China

Machine Learning-based Classification of Symptom Clusters and Online CBT Active, not recruiting

Other trials for the same condition

Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis Starting soon
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) Recruiting
A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression Starting soon
Anxiety and Depression in IBS: A Brain-Gut Axis Study Recruiting
Peripartum Mental Health Cohort Study in Guangzhou Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07112118 on ClinicalTrials.gov ↗ ← All trials in China